Nat Med:癌症专家倡议共享癌症基因组信息 共建大数据网络

2016-05-21 佚名 生物谷Bioon.com

                据贝尔法斯特女王大学的一位癌症研究专家介绍,全世界癌症患者的基因信息共享或可成为癌症预防和治疗的关键所在。 相关内容发表在国际学术期刊Nature Medicine上,文章通讯作者是来自女王大学癌症和细胞生物学中心的Mark Lawler教授。这篇文章着重强调了大数据在癌细胞研究和开发有效个体化治疗策略方面的潜

               

据贝尔法斯特女王大学的一位癌症研究专家介绍,全世界癌症患者的基因信息共享或可成为癌症预防和治疗的关键所在。

相关内容发表在国际学术期刊Nature Medicine上,文章通讯作者是来自女王大学癌症和细胞生物学中心的Mark Lawler教授。这篇文章着重强调了大数据在癌细胞研究和开发有效个体化治疗策略方面的潜在作用。Lawler教授还是GA4GH组织的联合主席,该组织成立于2013年,主要进行病人临床和基因数据的可靠,自愿和安全共享,为癌症研究建立一个共同框架。

GA4GH组织包含了40多个国家的超过400个机构,其中既有科学家,临床医生,还有病人以及IT和生命科学领域的公司企业。Lawler教授希望通过这篇文章的发表能够勾画出一个病人数据共享,帮助改善病人治疗效果的蓝图。

Lawler教授这样说道:“‘大数据’这个概念意味着需要通过高性能计算机分析的大量信息,能够从中找到一些模式,趋势以及相关性。在医学领域中,大数据包含了在疾病诊断和治疗过程中从病人处获得的临床以及基因信息。”

癌症是一类非常复杂的疾病,并且一直处于变化状态,每个病人的病情都不太相同。想要走在癌症斗争的前沿,关键在于正确理解癌症的进化过程。这需要对不同数据库以及不同研究机构掌握的信息进行分析,通过比较不同群组的病人,从中找到规律。因此必须打破“数据竖井”,共享基因和临床信息。

Lawler教授最后表示,数据共享就会带来技术以及伦理等方面的挑战,这篇文章对这些挑战进行了汇总和分析,并提出了一些可能的解决办法保证数据能够通过及时,可靠并且有效的途径进行共享。他们希望全世界的研究人员能够参与到这一蓝图中,共同开发“大数据”中蕴含的价值,最终建立一个癌症基因组的大数据网络。

原始出处:

Lillian L Siu, Mark Lawler, David Haussler, Bartha Maria Knoppers, Jeremy Lewin, Daniel J Vis, Rachel G Liao, Fabrice Andre, Ian Banks, J Carl Barrett, Carlos Caldas, Anamaria Aranha Camargo, Rebecca C Fitzgerald, Mao Mao, John E Mattison, William Pao, William R Sellers, Patrick Sullivan, Bin Tean Teh, Robyn L Ward, Jean Claude ZenKlusen, Charles L Sawyers & Emile E Voest.Facilitating a culture of responsible and effective sharing of cancer genome data.Nat Med.doi:10.1038/nm.4089 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2066995, encodeId=69c32066995ba, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Jan 11 18:45:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138127, encodeId=dca613812e14, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 15:17:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881054, encodeId=42931881054b0, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Nov 23 04:45:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591251, encodeId=567a159125180, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Mon May 23 09:45:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606923, encodeId=90911606923a3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon May 23 09:45:00 CST 2016, time=2016-05-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2066995, encodeId=69c32066995ba, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Jan 11 18:45:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138127, encodeId=dca613812e14, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 15:17:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881054, encodeId=42931881054b0, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Nov 23 04:45:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591251, encodeId=567a159125180, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Mon May 23 09:45:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606923, encodeId=90911606923a3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon May 23 09:45:00 CST 2016, time=2016-05-23, status=1, ipAttribution=)]
    2016-09-30 1e10c84am36(暂无匿称)

    拜读,好文

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2066995, encodeId=69c32066995ba, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Jan 11 18:45:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138127, encodeId=dca613812e14, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 15:17:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881054, encodeId=42931881054b0, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Nov 23 04:45:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591251, encodeId=567a159125180, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Mon May 23 09:45:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606923, encodeId=90911606923a3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon May 23 09:45:00 CST 2016, time=2016-05-23, status=1, ipAttribution=)]
    2016-11-23 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=2066995, encodeId=69c32066995ba, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Jan 11 18:45:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138127, encodeId=dca613812e14, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 15:17:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881054, encodeId=42931881054b0, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Nov 23 04:45:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591251, encodeId=567a159125180, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Mon May 23 09:45:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606923, encodeId=90911606923a3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon May 23 09:45:00 CST 2016, time=2016-05-23, status=1, ipAttribution=)]
    2016-05-23 chendoc248
  5. [GetPortalCommentsPageByObjectIdResponse(id=2066995, encodeId=69c32066995ba, content=<a href='/topic/show?id=2ec9e133569' target=_blank style='color:#2F92EE;'>#癌症基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71335, encryptionId=2ec9e133569, topicName=癌症基因)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/656F31B644588474D1C46903A7F84373/100, createdBy=4e842500199, createdName=ms24272190615788285182, createdTime=Wed Jan 11 18:45:00 CST 2017, time=2017-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138127, encodeId=dca613812e14, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 15:17:00 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881054, encodeId=42931881054b0, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Nov 23 04:45:00 CST 2016, time=2016-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591251, encodeId=567a159125180, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Mon May 23 09:45:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606923, encodeId=90911606923a3, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon May 23 09:45:00 CST 2016, time=2016-05-23, status=1, ipAttribution=)]

相关资讯

研发混合益生菌或可低成本治疗肝癌

由香港大学生物系副教授Hani El-Nezami博士及Gianni Panagiotou博士领导的科研团队,与该校李嘉诚医学院及东芬兰大学医学系合作,研发出一种对肝癌具有潜在治疗效果的混合益生菌“Prohep”,有望成为治疗肝癌的一种低成本方案。

颠覆!自闭症患者对癌症具有“免疫力”

《你是我的眼》这首歌相信很多人都不陌生,歌词“你是我的眼,带我领略四季的变换;你是我的眼,带我穿越拥挤的人潮;你是我的眼,带我阅读浩瀚的书海;因为你是我的眼,让我看见这世界就在我眼前…”感动了无数人。而现实生活还有这么些人,他们视力正常,可以看见光明,可是你却无法走进他们的世界。  自闭症(autism)又称孤独症、孤独性障碍(autistic disorder)等,是广泛性发

Oncotarget:新型无毒副作用疗法可治疗多种癌症

近日,刊登于国际杂志Oncotarget上的一项研究论文中,来自迈阿密大学米勒医学院的研究人员通过研究开发了一种新型无毒疗法来治疗多种类型的癌症;这种新型疗法基于2-脱氧葡萄糖(2-Deoxy-D-glucose,2-DG)和胆固醇药物非诺贝特的组合性疗法而开发。

Science:癌症免疫疗法重大突破,利用他人的T细胞抵抗癌症

在一项新的研究中,来自荷兰癌症研究所、挪威奥斯陆大学和丹麦哥本哈根大学的研究人员在癌症免疫疗法上取得新的突破,他们证实即便一个人自己的T细胞(一类免疫细胞)不能够识别和抵抗他们自身的肿瘤,但是其他人的T细胞可能会做到这点。相关研究结果于2016年5月19日在线发表在Science期刊上,论文标题为“Targeting of cancer neoantigens with donor-deriv

Trends Cancer:阻断细胞凋亡的反应可使癌症女性放化疗后仍保持生育能力

Trends Cancer:阻断细胞凋亡的反应可使癌症女性接受放化疗后仍保持生育能力通过靶向卵母细胞中的DNA损伤反应,可使得处于生殖年龄的癌症女性患者在放疗和化疗期间仍能保持他们的生殖能力,该治疗方法已在动物模型中取得成功。杰克逊实验室助理教授Ewelina bolcun博士以及来自德克萨斯大学MD安德森癌症中心的助理教授Terri L. Woodward博士在Trends in Cancer中

NEJM:易被误诊为癌症的脾组织植入症-案例报道

患者女,62岁,进行性呼吸困难。有每年40包烟的吸烟史。胸片:沿左侧膈肌有结节(图A,箭头),癌症不除外。此外患者还有肺气肿和轻度脊柱侧凸。既往史:28年前胸腹部枪伤,导致肝脏、左侧膈肌和脾损伤,进行开腹脾切除术。CT:左侧(图B,箭头)可见数个小的基底部的胸膜结节,以及横隔膜缺陷和脾床结节,与先前脾切除表现一致。通过锝-99m标记热损伤红细胞扫描证实了结节为脾组织,患者诊断为脾组织植入症。医生建